The outbreak of COVID-19 is set to benefit sales of paediatric consumer health products, with the landscape moving from value growth of 4% in 2019, to 5% value growth predicted for 2020.
Paediatric cough, cold and allergy remedies are expected to have the worst performance in 2020, recording a double-digit value decline. These products have already been struggling across the forecast period, due to a mistrust around cold medication, with consumers looking for more natural alternatives for their children.
Bayer Sante Familiale SAS is set to continue leading the landscape in 2020, with its popular and trusted nappy (diaper) rash cream. Nappy (diaper) rash treatments is expected to see positive results from the outbreak of COVID-19.
Following an uplift in growth in 2020, due to the outbreak of COVID-19 and stockpiling, paediatric consumer health is set to return to lower growth levels in 2021, when it will record 3% value growth. Growth is then set to remain steady and positive across the rest of the forecast period, driven by paediatric vitamins and dietary supplements and paediatric acetaminophen.
As with the adult landscape, over the counter paediatric medication is set to struggle across the forecast period, with numerous warnings and precautions surrounding certain OTC drugs - such as those to treat coughs, for example - contributing to the distrust French consumers have towards medications.
Over the forecast period, paediatric vitamins and dietary supplements is expected to continue leading value sales, with the growing health and wellness trend supporting growth. In addition, many consumers are keen to ensure they are doing all they can to support their child’s growth and development, with parents looking to add vitamin and dietary supplements to their children’s daily diets.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
Understand the latest market trends and future growth opportunities for the Paediatric consumer health industry in France with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Paediatric consumer health industry in France, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
This report originates from Passport, our Paediatric consumer health research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page